|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
1618765 |
003 |
ICU |
005 |
19970814004800.0 |
008 |
940524s1994 sz a b 000 0 eng d |
020 |
|
|
|a 3805558090
|
035 |
|
|
|a (ICU)BID18682689
|
035 |
|
|
|a (OCoLC)30564576
|
040 |
|
|
|a CGU
|c CGU$dOrLoB
|
245 |
0 |
0 |
|a Cytokines in cancer therapy /
|c volume editors, L. Bergmann, P.S. Mitrou.
|
260 |
|
|
|a Basel ;
|a New York :
|b Karger,
|c 1994.
|
300 |
|
|
|a x, 392 p. :
|b ill. ;
|c 25 cm.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
440 |
|
0 |
|a Beiträge zur Onkologie
|v vol. 46
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
0 |
|t The Cytokine Network /
|r F. R. Balkwill and M. S. Naylor --
|t Regulation of Major Histocompatibility Complex Class I Gene Expression in Oncogene-Transformed Mouse Fibroblasts /
|r B. Seliger, S. Lohmann, C. Huber and K. Pfizenmaier --
|t Combinations of Interferon-[alpha] with Other Cytokines as Initial and Second-Line Therapy of Chronic Myelogenous Leukemia /
|r O. Kloke --
|t The Role of Alpha-Interferon in Patients with Chronic Myeloid Leukemia Autografted in Chronic Phase /
|r P. De Fabritiis et al --
|t Interferon-[alpha] in the Treatment of CML: Comparison of Busulfan versus Hydroxyurea versus Interferon-[alpha] /
|r R. Hehlmann et al --
|t Clinical Significane of Interferons in the Treatment of Malignant Lymphomas /
|r M. Freund, H.-D. Kleine, P. Heussner and H. Poliwoda --
|t Interferon-[alpha] in the Treatment of B-Cell Chronic Lymphocytic Leukemia /
|r W. Knauf et al --
|t High-Dose Tumor Necrosis Factor-[alpha] in Combination with Interferon-[gamma] and Melphalan in Isolated Perfusion of the Limb for Irresectable Soft Tissue Sarcomas: A Highly Effective Approach to Achieve Limb Salvage /
|r A. M. M. Eggermont t al --
|t Potentiation of Growth Inhibition and Modulation of Differentiation in Human Malignant Glioblastomas by Combined Treatment with Recombinant Human Interferon-[alpha] and -[gamma] /
|r M. Doll, C. Huber and B. Seliger --
|t Immunotherapy and Chemotherapy in Anaplastic Thyroid Carcinoma - An Experimental Study /
|r H. J. C. Wenisch et al --
|t Endocrinologic Principles in the Therapeutic Use of Interleukin-2 /
|r K. A. Smith --
|t Activation and Therapy with Cytotoxic Lymphocytes: Current Dilemmas and New Directions /
|r E. Lotzova --
|t Tumor-Infiltrating Lymphocytes: Potential and Limitations to Their Use in Antineoplastic Therapy /
|r T. L. Whiteside --
|t The T-Cell Receptor [beta] Chain Variable Region Repertoire in Fresh and Cultured Lymphocytes Isolated from Human Malignant Melanomas /
|r E. Weidmann et al --
|t Interleukin-2 and Its Combination with Other Cytokines in Cancer Therapy /
|r L. Bergmann --
|t Early and Late Intravenous Interleukin-2 Infusion after Autologous Bone Marrow Transplantation: Report of Multicentric French Studies /
|r M. C. Favrot et al --
|t Immunotherapy in Marrow Transplantation - Interferon Early after Transplantation or IL-2-Activated Bone Marrow /
|r H.-G. Klingemann, H.-J. Gong, C. J. Eaves and G. L. Phillips --
|t The Local Availability of IL-2 Induces the Immune Recognition of an Otherwise 'Nonimmunogenic' Tumor /
|r F. Cavallo et al --
|t Subcutaneous rIL-2 in Advanced Melanoma and Kidney Carcinoma: Clinical and Biological Aspects /
|r M. Guida et al --
|t Treatment of Metastatic Melanoma with Interferon-[alpha] and High-Dose Interleukin-2 /
|r U. Keilholz et al --
|t Daily Alternating Administration of Interferon-[alpha]2b and Interleukin-2 Bolus Infusion in Two Different Dose Levels by Metastatic Renal Cell Cancer. Results of Two Phase II Studies /
|r L. Bergmann et al --
|t Treatment Strategies Employing Chemoimmunotherapy in Patients with Metastatic Renal Carcinoma /
|r J. Atzpodien, H. Kirchner and H. Poliwoda --
|t Inhalation of Natural Interleukin-2: Effectivity and Toxicity in Patients with Pulmonary Metastases of Renal Cell Carcinoma /
|r E. Huland, H. Heinzer, H. Schwaibold and H. Huland --
|t Antibody Formation to Interleukin-2 in Renal Cell Carcinoma Patients with Pulmonary Metastases Treated by Aerosol Therapy. Comparison of Western Blot and Enzyme-Linked Immunosorbent Assay Data /
|r U. Schwulera, E. Huland, W. G. Struff and R. Lissner --
|t No Antibody Formation in Cancer Patients Treated with Natural Interleukin-2 in Combination with Recombinant Interferon-[gamma] /
|r J. Knuver-Hopf et al --
|t Local Application of Lymphokine-Activated Killer Cells and Natural Interleukin-2 in Malignant Glioma Therapy /
|r F. Weber et al --
|t Real-Time Biospecific Interaction Analysis of Immobilized Interleukin-2 Receptor [beta]-Chain Peptides with Polyclonal Antibodies /
|r K. Schmitt et al --
|t The Total Cytokine Concept: The Influence of Soluble Receptors in the Cytokine Measurement /
|r D. Radoux and D. De Groote --
|t Development of Live Tumor Vaccines Using Retroviral Vectors for Transfer of Suicide Genes and Cytokines /
|r C. A. Mullen --
|t Generation of a Cellular Antitumor Immune Response by Retrovirally Mediated Cytokine Gene Transfer /
|r F. M. Rosenthal, K. Cronin, R. Guarini and B. Gansbacher --
|t Tumor-Cell-Targeted Interleukin-7 Gene Transfer Reveals T-Cell-Dependent Antitumor Activity in vivo /
|r H. Hock, M. Dorsch, T. Blankenstein and T. Diamantstein --
|t Detection of Cytokines Induced by and Involved in the Antitumor Response Provoked by Tumor Cell-Derived Interleukin-4 /
|r G. Richter, C. Platzer, T. Blankenstein and T. Diamantstein --
|t Phase I Dose Toxicity Clinical Evaluation of Interleukin-4 /
|r M. H. Gilleece et al --
|t Biological Properties of Human Interleukin-10 /
|r R. de Waal Malefyt and J. E. de Vries --
|t Transforming Growth Factor [beta] - Multiple Actions in Immune Function and Oncology /
|r J. Kekow and W. L. Gross --
|t Involvement of Cytokines in Graft-versus-Host Disease and Graft-versus-Leukemia Activity /
|r E. Holler et al --
|t Cytokine-Induced Adhesion Molecules and Tumor Spread /
|r A. Garofalo, R. Dossi and R. Giavazzi --
|t Up-Regulation of Adhesion Molecules by Immunotherapy as a Mechanism of Cytotoxicity in Renal Cell Cancer, Malignant Melanoma, and Acute Myelocytic Leukemia /
|r K. Fenchel, L. Bergmann, B. Jahn and P. S. Mitrou --
|t Immunological Detection and Surveillance of Residual Acute Myeloid Leukemia during Remission /
|r H. H. Gerhartz, H. Schmetzer and F. Mayer --
|t Regulation of H[subscript 4]biopterin Synthesis in Human Mononuclear Cells during Immune Response /
|r I. Ziegler, K. Schott and U. Schwulera --
|t Cytokines Directly Affect Contractility and Stress Protein Formation of Cardiac Myocytes /
|r I. Low-Friedrich et al --
|t Current Concepts and Future Prospects for Immunotherapeutic Approaches in Cancer Treatment /
|r T. L. Whiteside and R. B. Herberman.
|
650 |
|
0 |
|a Cytokines
|x Therapeutic use
|x Testing.
|
650 |
|
0 |
|a Cancer
|x Chemotherapy
|0 http://id.loc.gov/authorities/subjects/sh85019497
|
650 |
|
7 |
|a Cancer
|x Chemotherapy.
|2 fast
|0 http://id.worldcat.org/fast/fst00845327
|
650 |
|
7 |
|a Cytokines
|x Therapeutic use
|x Testing.
|2 fast
|0 http://id.worldcat.org/fast/fst00886276
|
655 |
|
7 |
|a Conference papers and proceedings.
|2 fast
|0 http://id.worldcat.org/fast/fst01423772
|
700 |
1 |
0 |
|a Bergmann, L.
|q (Lothar)
|0 http://id.loc.gov/authorities/names/no94018998
|1 http://viaf.org/viaf/122036710
|
700 |
1 |
0 |
|a Mitrou, Paris S.
|0 http://id.loc.gov/authorities/names/n86002712
|1 http://viaf.org/viaf/69015527
|
850 |
|
|
|a ICU
|
901 |
|
|
|a ToCBNA
|
903 |
|
|
|a HeVa
|
929 |
|
|
|a cat
|
999 |
f |
f |
|i d525dc9c-1a77-5549-a0fe-66a598d0a7d4
|s 68d717a8-00f2-5312-93ed-e359f984e8d2
|
928 |
|
|
|t Library of Congress classification
|a RC271.C95C987 1994
|l ASR
|c ASR-SciASR
|i 5907839
|
927 |
|
|
|t Library of Congress classification
|a RC271.C95C987 1994
|l ASR
|c ASR-SciASR
|e CRERAR
|b 39765614
|i 3065315
|